Cytodyn Inc (CYDY)

[B52T38]

Question for moneycrew (and others): I have no experience (as a stockholder) with a small bio company like CYDY when it "partners up" with a big fish like Roche. I assume everything is in the details - what are the terms of the partnership, what indication(s) are covered, what's the reimbursement - but to my question - do you have an expectation of what a "typical" big pharma partnership for one of indications might do to the share price?

Does teaming up with a big pharma result in a synergistic effect on the SP, i.e., does the agreement itself typically exceed the monetary sum of its parts?